Search For "orforglipron"
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3
Updated : 1 year, 1 month ago IST
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
Read More